Bexsero
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
58160-976 -
Package NDC
58160-976-20 -
Application number
BLA125546 -
SPL ID
db17d990-e6e2-450c-b9ed-923ec92df84d
What the source publishes
- Labeler
- GlaxoSmithKline Biologicals SA
- Active ingredients
- NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN
- Form
- INJECTION, SUSPENSION
- Routes
- INTRAMUSCULAR
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- VACCINE
Names this record is found by
- Bexsero
- NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN
- NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN
- NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN
- NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN
- NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE ANTIGEN
Complete source data
{
"name": "Bexsero",
"splId": "db17d990-e6e2-450c-b9ed-923ec92df84d",
"labels": [],
"routes": [
"INTRAMUSCULAR"
],
"labeler": "GlaxoSmithKline Biologicals SA",
"finished": true,
"packaging": [
{
"sample": false,
"description": "10 SYRINGE in 1 CARTON (58160-976-20) / .5 mL in 1 SYRINGE (58160-976-02)",
"package_ndc": "58160-976-20",
"identifierStatus": "well-formed",
"marketing_start_date": "20161201"
}
],
"productId": "58160-976_db17d990-e6e2-450c-b9ed-923ec92df84d",
"useDomain": "unknown",
"dosageForm": "INJECTION, SUSPENSION",
"productNdc": "58160-976",
"deaSchedule": null,
"genericName": "NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN",
"productType": "VACCINE",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN",
"strength": "50 ug/.5mL"
},
{
"name": "NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN",
"strength": "50 ug/.5mL"
},
{
"name": "NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN",
"strength": "50 ug/.5mL"
},
{
"name": "NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE ANTIGEN",
"strength": "25 ug/.5mL"
}
],
"applicationNumber": "BLA125546",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20161201",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "unknown",
"harmonizedIdentifiers": {},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:58160-976_db17d990-e6e2-450c-b9ed-923ec92df84d"